Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
University of Pennsylvania · George Mason University · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
226
total citations
- FWCI
- 32.74
- Percentile
- 100%
- References
- 51
Citations per year
Authors
16Topics & keywords
Topics
Keywords
- Adjuvant
- Immunogenicity
- Immune system
- Innate immune system
- Immunity
- Messenger RNA
- Lipid A
- Acquired immune system
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- NSNational Science FoundationAwards: CBET-2145491, CAREER, 2145491
- UOUniversity of PennsylvaniaAwards: P30 AI045008, P30 CA016520
- NANarodowa Agencja Wymiany AkademickiejAward: PNN/IWA/2019/00057
- NINational Institutes of HealthAwards: DP2 TR002776, P30 CA016520, AI045008, CA016520, P30 AI045008
- DODivision of Chemical, Bioengineering, Environmental, and Transport SystemsAwards: CBET-2145491, 2145491